Breakthrough Pill for Pancreatic Cancer | Denver News

FDA just approved a groundbreaking pill for advanced pancreatic cancer — a disease long considered nearly untreatable. Called daraxonrasib (sold as Rasonque), this daily medication targets the RAS protein, mutated in 90% of cases, and was once deemed “undruggable.” Clinical trials show patients lived nearly twice as long with far fewer side effects than standard chemo. One patient called it a “miracle drug,” reporting shrinking tumors and reduced pain. Though priced at $39,800 per month, the FDA’s fast-track approval signals urgency to save lives. This breakthrough could revolutionize treatment for other cancers too — including lung cancer — marking the start of a new era in oncology. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/e3c92be077be1081